Aureobasidin A [127785-64-2]
Referencia HY-P1975-1mg
embalaje : 1mg
Marca : MedChemExpress
Aureobasidin A (Basifungin) is a cyclic peptide antibiotic with oral activity. Aureobasidin A is an inhibitor of inositol phosphorylated ceramide synthetase AUR1. Aureobasidin A has antifungal and antiparasitic activity.
Para uso exclusivo en investigación. No vendemos a pacientes.
Síntesis de péptidos personalizados
Aureobasidin A Estructura química
No. CAS : 127785-64-2
This product is a controlled substance and not for sale in your territory.
Based on 2 publication(s) in Google Scholar
Ver todos los productos específicos de isoformas Parasite:
Descripciòn |
Aureobasidin A (Basifungin) is a cyclic peptide antibiotic with oral activity. Aureobasidin A is an inhibitor of inositol phosphorylated ceramide synthetase AUR1. Aureobasidin A has antifungal and antiparasitic activity[1][2][3]. |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
In Vitro |
Aureobasidin A (20 ng/mL, 24 h) can completely inhibit the growth of Candida albicans SC5314 [1] MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||
In Vivo |
Aureobasidin A (20, 40 mg/kg, oral) has a good therapeutic effect on systemic candida infection in mice, which is superior to fluconazole (HY-B0101) and amphotericin B (HY-B0221)[3]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||
Peso molecular |
1101.42 |
||||||||||||
Fòrmula |
C60H92N8O11 |
||||||||||||
No. CAS |
127785-64-2 |
||||||||||||
Appearance |
Solid |
||||||||||||
Color |
White to off-white |
||||||||||||
Structure Classification |
|
||||||||||||
Initial Source |
Aureobasidium pullulans R106 |
||||||||||||
Envío | Room temperature in continental US; may vary elsewhere. |
||||||||||||
Almacenamiento |
Sealed storage, away from moisture and light
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
||||||||||||
Solvente y solubilidad |
In Vitro:
DMSO : 50 mg/mL (45.40 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO) Preparing
Stock Solutions
View the Complete Stock Solution Preparation Table
*
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol) Concentration (start) × Volume (start) = Concentration (final) × Volume (final) This equation is commonly abbreviated as: C1V1 = C2V2 In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
Dosage mg/kgAnimal weight Dosing volume Number of animals Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO
+
%
+
%
Tween-80
+
%
Saline
The co-solvents required include: DMSO,
. All of co-solvents are available by MedChemExpress (MCE).
, Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration:
mg/mL
Method for preparing stock solution:
mg
drug dissolved in
μL
DMSO (Stock solution concentration: mg/mL).
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take
μL DMSO stock solution, add
μL .
μL , mix evenly, next add
μL Tween 80, mix evenly, then add
μL Saline.
If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
|
||||||||||||
Pureza y Documentación |
Purity: 99.36% |
||||||||||||
Referencias |
|
Complete Stock Solution Preparation Table
*
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
---|
DMSO | 1 mM | 0.9079 mL | 4.5396 mL | 9.0792 mL | 22.6980 mL |
5 mM | 0.1816 mL | 0.9079 mL | 1.8158 mL | 4.5396 mL | |
10 mM | 0.0908 mL | 0.4540 mL | 0.9079 mL | 2.2698 mL | |
15 mM | 0.0605 mL | 0.3026 mL | 0.6053 mL | 1.5132 mL | |
20 mM | 0.0454 mL | 0.2270 mL | 0.4540 mL | 1.1349 mL | |
25 mM | 0.0363 mL | 0.1816 mL | 0.3632 mL | 0.9079 mL | |
30 mM | 0.0303 mL | 0.1513 mL | 0.3026 mL | 0.7566 mL | |
40 mM | 0.0227 mL | 0.1135 mL | 0.2270 mL | 0.5674 mL |
Aureobasidin A Related Classifications
- Péptidos
- Peptide and Derivatives
- Antimicrobial Peptides Inhibitors and Substrates Therapeutic Peptides
- Inflammation/Immunology Infection
- Anti-infection
- Fungal Parasite